{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:15:55Z","timestamp":1788225355195,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":98,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Sichuan Science and Technology Program","award":["2023YFQ0095"],"award-info":[{"award-number":["2023YFQ0095"]}]},{"name":"International Cooperation Program of Science and Technology Department of Sichuan Province","award":["2023YFH0081"],"award-info":[{"award-number":["2023YFH0081"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-026-04370-4","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T11:35:21Z","timestamp":1779795321000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prediction of intravenous cyclophosphamide treatment efficacy in idiopathic inflammatory myopathies-associated interstitial lung disease patients: a nomogram based on radiomics and clinical factors"],"prefix":"10.1186","volume":"26","author":[{"given":"Deying","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinlan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuping","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"issue":"2","key":"4370_CR1","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1016\/S2665-9913(23)00322-3","volume":"6","author":"CM Connolly","year":"2024","unstructured":"Connolly CM, Gupta L, Fujimoto M, Machado PM, Paik JJ. Idiopathic inflammatory myopathies: current insights and future frontiers. Lancet Rheumatol. 2024;6(2):e115\u201327.","journal-title":"Lancet Rheumatol"},{"issue":"11","key":"4370_CR2","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41584-023-01033-0","volume":"19","author":"T Khoo","year":"2023","unstructured":"Khoo T, Lilleker JB, Thong BY, Leclair V, Lamb JA, Chinoy H. Epidemiology of the idiopathic inflammatory myopathies. Nat Rev Rheumatol. 2023;19(11):695\u2013712.","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"4370_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/BOR.0000000000001076","volume":"37","author":"F Duremala","year":"2025","unstructured":"Duremala F, Tiniakou E, Andrews J. Epidemiology of myositis. Curr Opin Rheumatol. 2025;37(2):121\u20137.","journal-title":"Curr Opin Rheumatol"},{"issue":"8","key":"4370_CR4","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1002\/art.42861","volume":"76","author":"SR Johnson","year":"2024","unstructured":"Johnson SR, Bernstein EJ, Bolster MB, Chung JH, Danoff SK, George MD, Khanna D, Guyatt G, Mirza RD, Aggarwal R, et al. 2023 American College of Rheumatology (ACR)\/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. Arthritis Rheumatol (Hoboken NJ). 2024;76(8):1182\u2013200.","journal-title":"Arthritis Rheumatol (Hoboken NJ)"},{"issue":"5","key":"4370_CR5","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/art.40418","volume":"70","author":"CT Deakin","year":"2018","unstructured":"Deakin CT, Campanilho-Marques R, Simou S, Moraitis E, Wedderburn LR, Pullenayegum E, Pilkington CA. Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling. Arthritis Rheumatol (Hoboken NJ). 2018;70(5):785\u201393.","journal-title":"Arthritis Rheumatol (Hoboken NJ)"},{"key":"4370_CR6","doi-asserted-by":"publisher","unstructured":"Vacchi C, Sebastiani M, Cassone G, Cerri S, Della Casa G, Salvarani C, Manfredi A. Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review. J Clin Med. 2020;9(2):407. https:\/\/doi.org\/10.3390\/jcm9020407.","DOI":"10.3390\/jcm9020407"},{"issue":"1","key":"4370_CR7","first-page":"Cd010908","volume":"1","author":"H Barnes","year":"2018","unstructured":"Barnes H, Holland AE, Westall GP, Goh NS, Glaspole IN. Cyclophosphamide for connective tissue disease-associated interstitial lung disease. Cochrane Database Syst Rev. 2018;1(1):Cd010908.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"4370_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s12016-020-08814-5","volume":"60","author":"T Vojinovic","year":"2021","unstructured":"Vojinovic T, Cavazzana I, Ceruti P, Fredi M, Modina D, Berlendis M, Franceschini F. Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis. Clin Rev Allergy Immunol. 2021;60(1):87\u201394.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"4370_CR9","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12916-016-0739-7","volume":"14","author":"J Jacob","year":"2016","unstructured":"Jacob J, Bartholmai BJ, Rajagopalan S, Brun AL, Egashira R, Karwoski R, Kokosi M, Wells AU, Hansell DM. Evaluation of computer-based computer tomography stratification against outcome models in connective tissue disease-related interstitial lung disease: a patient outcome study. BMC Med. 2016;14(1):190.","journal-title":"BMC Med"},{"issue":"10","key":"4370_CR10","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1007\/s11547-021-01389-x","volume":"126","author":"C Scapicchio","year":"2021","unstructured":"Scapicchio C, Gabelloni M, Barucci A, Cioni D, Saba L, Neri E. A deep look into radiomics. Radiol Med. 2021;126(10):1296\u2013311.","journal-title":"Radiol Med"},{"issue":"1","key":"4370_CR11","doi-asserted-by":"publisher","first-page":"e222830","DOI":"10.1148\/radiol.222830","volume":"308","author":"Z Shi","year":"2023","unstructured":"Shi Z, Huang X, Cheng Z, Xu Z, Lin H, Liu C, Chen X, Liu C, Liang C, Lu C, et al. MRI-based Quantification of Intratumoral Heterogeneity for Predicting Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer. Radiology. 2023;308(1):e222830.","journal-title":"Radiology"},{"issue":"8","key":"4370_CR12","doi-asserted-by":"publisher","first-page":"101146","DOI":"10.1016\/j.xcrm.2023.101146","volume":"4","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Zhou K, Sun Z, Wang H, Xie J, Zhang T, Sang S, Islam MT, Wang JY, Chen C, et al. Non-invasive tumor microenvironment evaluation and treatment response prediction in gastric cancer using deep learning radiomics. Cell Rep Med. 2023;4(8):101146.","journal-title":"Cell Rep Med"},{"key":"4370_CR13","doi-asserted-by":"publisher","unstructured":"Sun Z, Zhang T, Ahmad MU, Zhou Z, Qiu L, Zhou K, Xiong W, Xie J, Zhang Z, Chen C et al. Comprehensive assessment of immune context and immunotherapy response via noninvasive imaging in gastric cancer. J Clin Investig. 2024;134(6):e175834. https:\/\/doi.org\/10.1172\/JCI175834.","DOI":"10.1172\/JCI175834"},{"key":"4370_CR14","doi-asserted-by":"publisher","unstructured":"Yang CC, Chen CY, Kuo YT, Ko CC, Wu WJ, Liang CH, Yun CH, Huang WM. Radiomics for the Prediction of Response to Antifibrotic Treatment in Patients with Idiopathic Pulmonary Fibrosis: A Pilot Study. Diagnostics (Basel Switzerland). 2022;12(4):1002. https:\/\/doi.org\/10.3390\/diagnostics12041002.","DOI":"10.3390\/diagnostics12041002"},{"key":"4370_CR15","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.2147\/TCRM.S181043","volume":"14","author":"DY Feng","year":"2018","unstructured":"Feng DY, Zhou YQ, Xing YF, Li CF, Lv Q, Dong J, Qin J, Guo YF, Jiang N, Huang C, et al. Selection of glucocorticoid-sensitive patients in interstitial lung disease secondary to connective tissue diseases population by radiomics. Ther Clin Risk Manag. 2018;14:1975\u201386.","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"4370_CR16","doi-asserted-by":"publisher","first-page":"17070","DOI":"10.1038\/s41598-021-96292-w","volume":"11","author":"W Xu","year":"2021","unstructured":"Xu W, Wu W, Zhang D, Chen Z, Tao X, Zhao J, Wang K, Wang X, Zheng Y, Ye S. A novel CT scoring method predicts the prognosis of interstitial lung disease associated with anti-MDA5 positive dermatomyositis. Sci Rep. 2021;11(1):17070.","journal-title":"Sci Rep"},{"issue":"12","key":"4370_CR17","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tj\u00e4rnlund A, Bottai M, Werth VP, Pilkington C, Visser M, Alfredsson L, Amato AA, Barohn RJ, Liang MH, et al. 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017;76(12):1955\u201364.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"4370_CR18","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, King TE Jr., Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU, et al. An official American Thoracic Society\/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733\u201348.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"4370_CR19","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1002\/mp.14609","volume":"48","author":"F Shan","year":"2021","unstructured":"Shan F, Gao Y, Wang J, Shi W, Shi N, Han M, Xue Z, Shen D, Shi Y. Abnormal lung quantification in chest CT images of COVID-19 patients with deep learning and its application to severity prediction. Med Phys. 2021;48(4):1633\u201345.","journal-title":"Med Phys"},{"issue":"6","key":"4370_CR20","doi-asserted-by":"publisher","first-page":"065031","DOI":"10.1088\/1361-6560\/abe838","volume":"66","author":"F Shi","year":"2021","unstructured":"Shi F, Xia L, Shan F, Song B, Wu D, Wei Y, Yuan H, Jiang H, He Y, Gao Y, et al. Large-scale screening to distinguish between COVID-19 and community-acquired pneumonia using infection size-aware classification. Phys Med Biol. 2021;66(6):065031.","journal-title":"Phys Med Biol"},{"key":"4370_CR21","doi-asserted-by":"publisher","first-page":"107905","DOI":"10.1016\/j.compbiomed.2023.107905","volume":"169","author":"Y Wang","year":"2024","unstructured":"Wang Y, Liu ZL, Yang H, Li R, Liao SJ, Huang Y, Peng MH, Liu X, Si GY, He QZ, et al. Prediction of viral pneumonia based on machine learning models analyzing pulmonary inflammation index scores. Comput Biol Med. 2024;169:107905.","journal-title":"Comput Biol Med"},{"issue":"3","key":"4370_CR22","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1093\/rheumatology\/kead263","volume":"63","author":"Y Li","year":"2024","unstructured":"Li Y, Deng W, Zhou Y, Luo Y, Wu Y, Wen J, Cheng L, Liang X, Wu T, Wang F, et al. A nomogram based on clinical factors and CT radiomics for predicting anti-MDA5\u2009+\u2009DM complicated by RP-ILD. Rheumatology (Oxford). 2024;63(3):809\u201316.","journal-title":"Rheumatology (Oxford)"},{"key":"4370_CR23","doi-asserted-by":"publisher","unstructured":"Branca JJV, Veltro C, Guarnieri G, Pacini A, Paternostro F. Morphological variations of the lung: accessory fissures and lobes. Anat Histol Embryol. 2023;52(6):983\u20138. https:\/\/doi.org\/10.1111\/ahe.12958.","DOI":"10.1111\/ahe.12958"},{"issue":"1","key":"4370_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41584-023-01054-9","volume":"20","author":"X Lu","year":"2024","unstructured":"Lu X, Peng Q, Wang G. Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progress. Nat Rev Rheumatol. 2024;20(1):48\u201362.","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"4370_CR25","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1136\/annrheumdis-2020-217230","volume":"80","author":"P Spagnolo","year":"2021","unstructured":"Spagnolo P, Distler O, Ryerson CJ, Tzouvelekis A, Lee JS, Bonella F, Bouros D, Hoffmann-Vold AM, Crestani B, Matteson EL. Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs). Ann Rheum Dis. 2021;80(2):143\u201350.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"4370_CR26","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1684\/ejd.2019.3634","volume":"29","author":"SI Motegi","year":"2019","unstructured":"Motegi SI, Sekiguchi A, Toki S, Kishi C, Endo Y, Yasuda M, Ikeuchi H, Sakairi T, Hara K, Yamaguchi K, et al. Clinical features and poor prognostic factors of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with rapid progressive interstitial lung disease. Eur J dermatology: EJD. 2019;29(5):511\u20137.","journal-title":"Eur J dermatology: EJD"},{"issue":"3","key":"4370_CR27","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1007\/s10753-023-01790-w","volume":"46","author":"L Cheng","year":"2023","unstructured":"Cheng L, Li Y, Wu Y, Luo Y, Zhou Y, Liao Z, Wen J, Liang X, Wu T, Tan C, et al. Risk of Early Infection in Idiopathic Inflammatory Myopathies: Cluster Analysis Based on Clinical Features and Biomarkers. Inflammation. 2023;46(3):1036\u201346.","journal-title":"Inflammation"},{"issue":"11","key":"4370_CR28","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1093\/rheumatology\/kead638","volume":"63","author":"JR Hannah","year":"2024","unstructured":"Hannah JR, Lawrence A, Martinovic J, Naqvi M, Chua F, Kouranos V, Ali SS, Stock C, Owens C, Devaraj A, et al. Antibody predictors of mortality and lung function trends in myositis spectrum interstitial lung disease. Rheumatology (Oxford). 2024;63(11):3080\u201390.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"4370_CR29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1136\/thx.2006.069237","volume":"63","author":"I Tillie-Leblond","year":"2008","unstructured":"Tillie-Leblond I, Wislez M, Valeyre D, Crestani B, Rabbat A, Israel-Biet D, Humbert M, Couderc LJ, Wallaert B, Cadranel J. Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset. Thorax. 2008;63(1):53\u20139.","journal-title":"Thorax"},{"issue":"4\u20136","key":"4370_CR30","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00281-024-01003-y","volume":"45","author":"T Kageyama","year":"2024","unstructured":"Kageyama T, Ito T, Tanaka S, Nakajima H. Physiological and immunological barriers in the lung. Semin Immunopathol. 2024;45(4\u20136):533\u201347.","journal-title":"Semin Immunopathol"},{"key":"4370_CR31","doi-asserted-by":"publisher","first-page":"110545","DOI":"10.1016\/j.intimp.2023.110545","volume":"122","author":"M Chen","year":"2023","unstructured":"Chen M, Wang J, Yuan M, Long M, Sun Y, Wang S, Luo W, Zhou Y, Zhang W, Jiang W, et al. AT2 cell-derived IgA trapped by the extracellular matrix in silica-induced pulmonary fibrosis. Int Immunopharmacol. 2023;122:110545.","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"4370_CR32","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.chest.2019.12.005","volume":"157","author":"JJ Solomon","year":"2020","unstructured":"Solomon JJ, Matson S, Kelmenson LB, Chung JH, Hobbs SB, Rosas IO, Dellaripa PF, Doyle TJ, Poli S, Esposito AJ, et al. IgA Antibodies Directed Against Citrullinated Protein Antigens Are Elevated in Patients With Idiopathic Pulmonary Fibrosis. Chest. 2020;157(6):1513\u201321.","journal-title":"Chest"},{"issue":"1","key":"4370_CR33","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12931-019-1195-7","volume":"20","author":"P Heukels","year":"2019","unstructured":"Heukels P, van Hulst JAC, van Nimwegen M, Boorsma CE, Melgert BN, von der Thusen JH, van den Blink B, Hoek RAS, Miedema JR, Neys SFH, et al. Enhanced Bruton\u2019s tyrosine kinase in B-cells and autoreactive IgA in patients with idiopathic pulmonary fibrosis. Respir Res. 2019;20(1):232.","journal-title":"Respir Res"},{"issue":"2","key":"4370_CR34","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/cei.12636","volume":"181","author":"L Ten Klooster","year":"2015","unstructured":"Ten Klooster L, van Moorsel CH, Kwakkel-van Erp JM, van Velzen-Blad H, Grutters JC. Immunoglobulin A in serum: an old acquaintance as a new prognostic biomarker in idiopathic pulmonary fibrosis. Clin Exp Immunol. 2015;181(2):357\u201361.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"4370_CR35","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1002\/jmv.26437","volume":"93","author":"M Xue","year":"2021","unstructured":"Xue M, Zhang T, Hu H, Huang Z, Zhen Y, Liang Y, Zeng Y, Jin T, Zhou L, Zhang XD, et al. Predictive effects of IgA and IgG combination to assess pulmonary exudation progression in COVID-19 patients. J Med Virol. 2021;93(3):1443\u20138.","journal-title":"J Med Virol"},{"issue":"12","key":"4370_CR36","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1111\/crj.13720","volume":"17","author":"C Wang","year":"2023","unstructured":"Wang C, Yang H, Li T, Wen Y, Yang H, Tang W, Li L, Sun S. Analysis of characteristics related to interstitial lung disease or pulmonary hypertension in patients with dermatomyositis. Clin Respir J. 2023;17(12):1328\u201340.","journal-title":"Clin Respir J"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04370-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04370-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04370-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:58:38Z","timestamp":1788224318000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12890-026-04370-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4370"],"URL":"https:\/\/doi.org\/10.1186\/s12890-026-04370-4","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"7 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study was reviewed by the Ethics Committee of Sichuan University under ethics number is No.341 (2022). This chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Given the retrospective nature of the study and the use of de-identified patient data, the requirement for informed consent was waived by our Ethics Committee.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"389"}}